Human medicines European public assessment report (EPAR): Cialis, tadalafil, Erectile Dysfunction, Date of authorisation: 12/11/2002, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Cialis, tadalafil, Erectile Dysfunction, Date of authorisation: 12/11/2002, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Ozawade, pitolisant, Sleep Apnea, Obstructive, Date of authorisation: 01/09/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ozawade, pitolisant, Sleep Apnea, Obstructive, Date of authorisation: 01/09/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Ocaliva, obeticholic acid, Liver Cirrhosis, Biliary, Date of authorisation: 12/12/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Ocaliva, obeticholic acid, Liver Cirrhosis, Biliary, Date of authorisation: 12/12/2016, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Praluent, alirocumab, Dyslipidemias, Date of authorisation: 23/09/2015, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Praluent, alirocumab, Dyslipidemias, Date of authorisation: 23/09/2015, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 21/03/2007, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Xelevia, sitagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 21/03/2007, Revision: 39, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness